Sonnet BioTherapeutic News

Sonnet BioTherapeutic | ARS: Annual Report to Security Holders

Aug 19 17:33 ET

Sonnet BioTherapeutic | DEF 14A: Definitive information statements

Aug 19 17:28 ET

Sonnet BioTherapeutic | 8-K: Current report

Aug 19 08:52 ET

Sonnet BioTherapeutic | 10-Q: Q3 2024 Earnings Report

Aug 14 08:49 ET

Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Aug 14 08:44 ET

Sonnet BioTherapeutic | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Aug 9 17:33 ET

Sonnet BioTherapeutic | 8-K: Current report

Aug 9 16:08 ET

Sonnet BioTherapeutic | 8-K: Current report

Jul 24 08:39 ET

Sonnet BioTherapeutic | EFFECT: Others

Jul 16 06:02 ET

Sonnet BioTherapeutic | 424B3: Prospectus

Jul 15 17:10 ET

Sonnet BioTherapeutic | CORRESP: CORRESP

Jul 11 12:42 ET

Sonnet BioTherapeutic | UPLOAD: Others

Jul 10 12:42 ET

Sonnet BioTherapeutic | S-3: Registration statement for specified transactions by certain issuers

Jul 5 16:08 ET

Sonnet BioTherapeutic | 8-K: Current report

Jun 20 16:52 ET

Sonnet BioTherapeutic | 8-K: Current report

Jun 14 12:47 ET

Sonnet BioTherapeutic | 8-K: Current report

Jun 13 08:18 ET

Sonnet BioTherapeutic | 8-K: Current report

May 22 07:39 ET

Sonnet BioTherapeutic | 8-K: Current report

May 20 09:30 ET

Sonnet BioTherapeutic | EFFECT: Others

May 17 06:08 ET

Sonnet BioTherapeutic | 424B3: Prospectus

May 16 16:23 ET